TLDR Rodent models of PCOS show some similar and some different lipid changes compared to humans.
The study investigates the plasma lipid profiles in rodent models of polycystic ovarian syndrome (PCOS) using a targeted mass spectrometry-based lipidomics workflow. The research found that letrozole treatment in rats significantly increased levels of 5α-androstene-3,17-dione and testosterone, while dihydrotestosterone treatment increased dehydroepiandrosterone-sulphate and allopregnanolone but decreased testosterone, progesterone, pregnenolone, and D-sphingosine. Both models showed reduced levels of 25-hydroxycholesterol and leukotriene C4, and increased 4-cholesten-3-one, which are not typically altered in human PCOS. These findings suggest that while some lipid changes in these rodent models are similar to human PCOS, others are not, indicating the complexity of using these models for PCOS research.
82 citations
,
May 2016 in “Best Practice & Research in Clinical Obstetrics & Gynaecology” The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.
4025 citations
,
December 2003 in “Human Reproduction” The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.
84 citations
,
November 2003 in “European journal of endocrinology” Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.
255 citations
,
October 1985 in “The Journal of Clinical Endocrinology & Metabolism” Spironolactone treatment increases the amount of testosterone available in the body.
75 citations
,
February 2016 in “The Journal of Sexual Medicine” Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.
1 citations
,
June 2019 in “Innovare journal of medical sciences” Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.
13 citations
,
August 2016 in “Reproduction” High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.
December 2023 in “Frontiers in endocrinology” Excess androgens may cause PCOS, not just be a symptom.
55 citations
,
May 2019 in “Journal of Endocrinology” Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.